Emily joined Mtech Access in 2019 following completion of her integrated Master’s degree in Biosciences at Durham University. During her time at Mtech Access, Emily has progressed from Analyst to Consultant, gaining valuable experience conducting and managing a diverse range of evidence synthesis projects for both HTA and market access. Her experience spans a multitude of disease areas from oncology to rare diseases. She has a particular interest in neurobiology, conducting her Master’s research project in Parkinson’s disease.
Emily’s expertise conducting systematic and targeted literature reviews spans a range of types and subsequent deliverables. She has led multiple clinical, economic, epidemiology, and burden literature reviews, in addition to conducting feasibility assessments for indirect treatment comparisons. Her experience across a variety of complex projects has refined both a skill and enjoyment for pragmatic problem-solving when dealing with individual project demands.
